Citation Impact

Citing Papers

Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
2017
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
2017 Standout
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
Astrocytes: biology and pathology
2009 Standout
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
2019 Standout
Variable selection for generalized canonical correlation analysis
2014
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
2011
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
2015 Standout
mixOmics: An R package for ‘omics feature selection and multiple data integration
2017 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
2020 Standout
The Intrinsically Disordered Protein Atg13 Mediates Supramolecular Assembly of Autophagy Initiation Complexes
2016 StandoutNobel
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
2015
Glioblastoma and Other Malignant Gliomas
2013 Standout
The Molecular Signatures Database Hallmark Gene Set Collection
2015 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Children's Oncology Group's 2013 blueprint for research: Central nervous system tumors
2012
Diffuse intrinsic pontine glioma: poised for progress
2012
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Genomic Insights into Diffuse Intrinsic Pontine Glioma
2017
Advances in the molecular genetics of gliomas — implications for classification and therapy
2016
Targeting apoptosis in cancer therapy
2020 Standout
Nasopharyngeal carcinoma
2015 Standout
Autophagy in Human Health and Disease
2013 Standout
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
2016
Autophagy and cancer therapy
2011
Self-consumption: the interplay of autophagy and apoptosis
2014 Standout
Glioblastoma: pathology, molecular mechanisms and markers
2015
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
2015 Standout
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
2013
Targeting autophagy in cancer
2017 Standout
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
2017
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The UCSC Cancer Genomics Browser: update 2015
2014
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
2014
Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures
2012
ROS signalling in the biology of cancer
2017 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Autophagy and Cancer Therapy
2014
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
2015 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
Spermidine in health and disease
2018 StandoutScience
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
2015
Atg13 HORMA domain recruits Atg9 vesicles during autophagosome formation
2015 StandoutNobel
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
2014
Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics
2018
PDGF Receptors in Tumor Biology: Prognostic and Predictive Potential
2014
BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy
2014
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Modeling and Targeting MYC Genes in Childhood Brain Tumors
2017
Biomarkers in tumors of the central nervous system – a review
2019
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Variable selection for generalized canonical correlation analysis.
2014

Works of Felipe Andreiuolo being referenced

Copy Number Gain of 1q25 Predicts Poor Progression-Free Survival for Pediatric Intracranial Ependymomas and Enables Patient Risk Stratification: A Prospective European Clinical Trial Cohort Analysis on Behalf of the Children's Cancer Leukaemia Group (CCLG), Société Française d'Oncologie Pédiatrique (SFOP), and International Society for Pediatric Oncology (SIOP)
2012
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
2015
Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas
2012
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
2010
Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma
2011
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling
2016
Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma
2014
GFAPδ immunostaining improves visualization of normal and pathologic astrocytic heterogeneity
2008
Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion
2015
A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
2009
Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens
2012
A Global View on the Availability of Methods and Information in the Neuropathological Diagnostics of CNS Tumors: Results of an International Survey Among Neuropathological Units
2016
Co‐occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma
2016
Rankless by CCL
2026